Bloomberg -- Merck KGaA’s $6 billion purchase of U.S. biotechnology equipment supplier Millipore Corp. is “worth every euro,” Chief Executive Officer Karl-Ludwig Kley told shareholders at the annual general meeting in Frankfurt today.
Bloomberg -- Merck KGaA’s $6 billion purchase of U.S. biotechnology equipment supplier Millipore Corp. is “worth every euro,” Chief Executive Officer Karl-Ludwig Kley told shareholders at the annual general meeting in Frankfurt today.
